Connection
Wells Messersmith to Caveolin 1
This is a "connection" page, showing publications Wells Messersmith has written about Caveolin 1.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.078 |
|
|
|
-
Messersmith WA, Rajeshkumar NV, Tan AC, Wang XF, Diesl V, Choe SE, Follettie M, Coughlin C, Boschelli F, Garcia-Garcia E, Lopez-Rios F, Jimeno A, Hidalgo M. Efficacy and pharmacodynamic effects of bosutinib (SKI-606), a Src/Abl inhibitor, in freshly generated human pancreas cancer xenografts. Mol Cancer Ther. 2009 Jun; 8(6):1484-93.
Score: 0.078